Synthelis Biotech
PrivateLast Round
Grant
Dec 12, 2024
Total Funding Raised
$830,000
Company Overview
Synthelis Biotech is a biotechnology company that provides cell-free protein expression systems and bioluminescence solutions for pharmaceutical, biomedical, and academic research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthelis Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Synthelis Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2024 | ||||
| M&A | Nov 24, 2023 | ||||
| Seed | Jan 21, 2014 |
Synthelis Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Grenoble Angels | Seed |
| Kreaxi | Seed |
| Savoie Mont Blanc Angels | Seed |
| Bpifrance | Grant |
Synthelis Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synthelis Biotech's valuation, stock price, and market status.